Verde Technologies Announces Twin Cities Orthopedics to Distribute Deterra™ Drug Deactivation System to Patients

MINNEAPOLIS, May 19, 2015 /PRNewswire/ -- Verde Technologies announced that Golden Valley-based Twin Cities Orthopedics, the largest orthopedic group in Minnesota, has become its most recent partner in the fight against prescription drug abuse and misuse. Twin Cities Orthopedics is the first orthopedic group to join Verde's Deterra partnership program, which provides an environmentally and socially responsible way to safely and easily deactivate and dispose of unused prescription medications through the Deterra Drug Deactivation System. Through this partnership program, Twin Cities Orthopedics will provide surgery patients at its Edina location with Deterra System pouches and educational information at the time of discharge to accompany their prescriptions, so they can safely deactivate unused medications in the privacy of their homes. There are plans to expand the program beyond the Edina location in the future.

"We see so much potential in having Twin Cities Orthopedics join the partnership program, and lead the way in empowering patients to safely deactivate and dispose of leftover prescriptions," said Jason Sundby, president and CEO of Verde Technologies. "Providing the Deterra System to patients along with their prescriptions is an extremely effective way to place the power to reduce prescription drug abuse and misuse directly in their hands."

The Deterra System utilizes patented MAT₁₂™ Molecular Adsorption Technology to deactivate unwanted, unneeded opioids, antibiotics, transdermal patches and other prescription drugs, rendering them ineffective for misuse and safe for the environment. The Deterra System features a pouch containing MAT₁₂, a proprietary activated carbon that bonds to pharmaceutical compounds when water is added, rendering drugs ineffective and safe for disposal quickly in any setting – home, clinic or hospital.

Deterra Partnership Program
To help organizations actively demonstrate social responsibility, Verde created the Deterra partnership program for companies and advocacy groups, such as manufacturers, health insurers, pharmacies, hospitals and surgery centers, community organizations and police departments. For organizations committed to supporting and implementing solutions to reduce ongoing issues of prescription drug abuse and misuse, the Deterra partnership program provides a cost-effective, environmentally and socially responsible way to quell the urgent issue through distribution of the Deterra System pouches.

For more information on the Deterra System or partnership program, visit www.DeterraSystem.com, or contact [email protected].

About Verde Technologies
Minneapolis-based Verde Technologies is a privately-owned company committed to developing research-based, scientifically proven solutions to reduce drug abuse, misuse and negative environmental impact. The Deterra Drug Deactivation System is powered by patented MAT₁₂ Molecular Adsorption Technology, which deactivates prescription drugs using proprietary activated carbon. The technology is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive and ineffective for misuse and safe for the environment. For more information or to order, please visit www.DeterraSystem.com or follow @deterrasystem on Twitter.

SOURCE Verde Technologies

Related Links

http://www.DeterraSystem.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED